These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26802722)

  • 61. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
    Yanaba K
    J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.
    Shalev T; Haviv Y; Segal E; Ehrenfeld M; Pauzner R; Levy Y; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(4):380-6. PubMed ID: 16956427
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Systemic sclerosis and macrovascular involvement: Status of the issue in 2019].
    Bertolino J; Scafi M; Benyamine A; Aissi K; Boufi M; Schleinitz N; Sarlon G; Rossi P; Granel B
    J Med Vasc; 2019 Dec; 44(6):400-421. PubMed ID: 31761307
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
    Thakkar V; Nikpour M; Stevens WM; Proudman SM
    Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pulmonary hypertension in systemic sclerosis.
    Chatterjee S
    Semin Arthritis Rheum; 2011 Aug; 41(1):19-37. PubMed ID: 21047671
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.
    Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Scleroderma--clinical and pathological advances.
    Denton CP; Black CM
    Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.
    Marí-Alfonso B; Simeón-Aznar CP; Guillén-Del Castillo A; Rubio-Rivas M; Trapiella-Martínez L; Todolí-Parra JA; Rodríguez Carballeira M; Marín-Ballvé A; Iniesta-Arandia N; Colunga-Argüelles D; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas Hitos JA; Chamorro AJ; Madroñero-Vuelta AB; Perales-Fraile I; Pla-Salas X; Fernández-De-La-Puebla RA; Fonollosa-Pla V; Tolosa-Vilella C; ;
    Semin Arthritis Rheum; 2018 Jun; 47(6):849-857. PubMed ID: 29246416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
    Sobanski V; Launay D; Hachulla E; Humbert M
    Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. N-TproBNP as biomarker in systemic sclerosis.
    Schioppo T; Artusi C; Ciavarella T; Ingegnoli F; Murgo A; Zeni S; Chighizola C; Meroni PL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):292-301. PubMed ID: 22669751
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.
    Castelino FV; Varga J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [New trends in diagnosis and treatment of systemic sclerosis].
    Becvár R; Stork J; Jansa P
    Vnitr Lek; 2006; 52(7-8):712-7. PubMed ID: 16967613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Update in systemic sclerosis-associated pulmonary arterial hypertension.
    Gashouta MA; Humbert M; Hassoun PM
    Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recommendations for diagnosis and treatment of systemic sclerosis in China].
    Zou HJ; Zhu XX; Dai SM; Wang XB; Zhao DB; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Aug; 61(8):874-882. PubMed ID: 35922211
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vascular complications of scleroderma.
    Guiducci S; Giacomelli R; Cerinic MM
    Autoimmun Rev; 2007 Sep; 6(8):520-3. PubMed ID: 17854742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systemic sclerosis and cancer.
    Marasini B; Conciato L; Belloli L; Massarotti M
    Int J Immunopathol Pharmacol; 2009; 22(3):573-8. PubMed ID: 19822074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.